Los Angeles Capital Management LLC Biogen Inc. Transaction History

Los Angeles Capital Management LLC

$27.9 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$275.25 - $318.06 $16.7 Million - $19.3 Million	-60,617 Reduced 98.35%	1,014 $288,000
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $35.8 Million - $40.8 Million	-139,445 Reduced 69.35%	61,631 $17.1 Million
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $12.3 Million - $15 Million	48,908 Added 32.14%	201,076 $55.7 Million
Q3 2022 Nov 02, 2022	BUY	$194.69 - $268.46 $21.6 Million - $29.8 Million	111,159 Added 271.06%	152,168 $40.6 Million
Q2 2022 Aug 05, 2022	BUY	$187.54 - $223.02 $4.96 Million - $5.9 Million	26,464 Added 181.95%	41,009 $8.36 Million
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $1.84 Million - $2.32 Million	9,490 Added 187.73%	14,545 $3.06 Million
Q4 2021 Feb 03, 2022	BUY	$223.92 - $287.77 $622,945 - $800,576	2,782 Added 122.39%	5,055 $1.21 Million
Q3 2021 Nov 08, 2021	SELL	$282.99 - $369.05 $515,041 - $671,671	-1,820 Reduced 44.47%	2,273 $643,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $9.61 Million - $15.4 Million	-37,107 Reduced 90.07%	4,093 $1.42 Million
Q1 2021 May 05, 2021	SELL	$242.95 - $284.63 $2.59 Million - $3.04 Million	-10,679 Reduced 20.58%	41,200 $11.5 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $46.1 Million - $69.4 Million	-195,234 Reduced 79.01%	51,879 $12.7 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $1.83 Million - $2.12 Million	-6,920 Reduced 2.72%	247,113 $70.1 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $4.44 Million - $5.88 Million	17,166 Added 7.25%	254,033 $68 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $44 Million - $55.8 Million	-163,714 Reduced 40.87%	236,867 $74.9 Million
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $64.5 Million - $89.1 Million	292,927 Added 272.1%	400,581 $119 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $3.01 Million - $3.37 Million	13,831 Added 14.74%	107,654 $25.1 Million
Q2 2019 Jul 29, 2019	BUY	$219.29 - $241.72 $4.94 Million - $5.44 Million	22,505 Added 31.56%	93,823 $21.9 Million
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $4.3 Million - $6.72 Million	19,834 Added 38.52%	71,318 $16.9 Million
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $16,988 - $21,517	61 Added 0.12%	51,484 $15.5 Million
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $38.7 Million - $50.6 Million	-131,733 Reduced 71.92%	51,423 $18.2 Million
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $29.5 Million - $35.2 Million	-114,664 Reduced 38.5%	183,156 $53.2 Million
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $9.81 Million - $13.9 Million	37,730 Added 14.51%	297,820 $81.5 Million
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $32.1 Million - $35.9 Million	104,237 Added 66.88%	260,090 $82.9 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $3.77 Million - $4.43 Million	13,422 Added 9.42%	155,853 $48.8 Million
Q2 2017 Aug 09, 2017	BUY	N/A	142,431	142,431 $38.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account